当前位置：首页 > 文献互助 > 互助详情

期刊论文Bispecific antibody and chimeric antigen receptor (CAR) modified T-cell in the treatment of multiple myeloma: Where do we stand today?复制

用户Zu1_OL3pbbwg 2小时前 8 待确认帖子自动结束时间: 2026-02-08 12:47:22

1. 请及时下载文件确认是否正确, 系统将在 2026-02-10 12:47:27 删除文件

2. 如若文件有误请驳回应助文件, 求助状态即回到求助中

3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1016/j.lpm.2024.104265复制

文献链接:复制

其他信息:

上一篇：Targets Selection for Precision Therapy of Relapsed/Refractory Multiple Myeloma: the Latest Advancements

下一篇：Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)

互助时间线

2026-02-03 12:47:27 [上传文件]

文献之光上传了文件(pdf 700.87 KB), 求助状态变成待确认

2026-02-03 12:47:22 [发起求助]

最新发布的求助

Do institutional factors influence the opportunities for social organizations to participate in community governance? An empirical study based on Guangdong, Hunan and Qinghai provinces 2分钟前

…治疗性药物组合RYZ811（诊断用）和RYZ801（治疗用）用于曾治疗过不可切除肝细胞癌的草甘-3阳性（GPC3 ）患者...... 5分钟前

阿罗洛尔治疗原发性高血压的优势与来自东亚的证据 16分钟前

Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy 53分钟前

An orally bioavailable MrgprX1-positive allosteric modulator alleviates certain neuropathic pain–related behaviors in humanized mice 1小时前

Novel Topical Esmolol Hydrochloride (Galnobax) for Diabetic Foot Wound: Phase 1/2, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Parallel-Group Study 1小时前

Equity Incentives and Corporate Innovation: A Case Study of Joyoung Co., Ltd. 1小时前

Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a) 2小时前

Bispecific antibody and chimeric antigen receptor (CAR) modified T-cell in the treatment of multiple myeloma: Where do we stand today? 2小时前

Targets Selection for Precision Therapy of Relapsed/Refractory Multiple Myeloma: the Latest Advancements 2小时前

Long-term serological, virological and histological responses to RNA inhibition by ARC-520 in Chinese chronic hepatitis B patients on entecavir treatment 3小时前

JNJ-73763989 pharmacokinetics and safety: Liver-targeted siRNAs against hepatitis B virus, in Japanese and non-Japanese healthy adults, and combined with JNJ-56136379 and a nucleos(t)ide analogue in patients with chronic hepatitis B 3小时前